| P50 | author | Hagop Kantarjian | Q60394812 |
| | Srdan Verstovsek | Q64026418 |
| | Sherry Pierce | Q66385417 |
| | Matjaž Sever | Q114304868 |
| | Lingsha Zhou | Q114427963 |
| P2093 | author name string | Alfonso Quintás-Cardama | |
| P2860 | cites work | JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis | Q24609999 |
| | A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera | Q28241887 |
| | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis | Q29614337 |
| | A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 |
| | Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders | Q29618853 |
| | Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation | Q34405385 |
| | Karyotype and molecular cytogenetic studies in polycythemia vera | Q36113006 |
| | Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs). | Q37255020 |
| | Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates | Q46849228 |
| | Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information. | Q51978963 |
| | A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. | Q53312448 |
| | Cytogenetic studies in Philadelphia chromosome-negative myeloproliferative disorders, particularly polycythaemia rubra vera. | Q53578405 |
| | A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course | Q68463829 |
| | A chromosomal profile of polycythemia vera | Q69782236 |
| | Chromosome studies in 104 patients with polycythemia vera | Q70115339 |
| | Karyotypic patterns and their clinical significance in polycythemia vera | Q72017030 |
| | Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation | Q80575698 |
| | Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia | Q80996436 |
| | HMGA2 overexpression in polycythemia vera with t(12;21)(q14;q22) | Q81248776 |
| | Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders | Q81442307 |
| P433 | issue | 12 | |
| P304 | page(s) | 2667-2670 | |
| P577 | publication date | 2013-04-17 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Significance of cytogenetic abnormalities in patients with polycythemia vera | |
| P478 | volume | 54 | |